Market Overview
The UAE cardiovascular devices market represents one of the most developed healthcare technology segments in the Middle East and Africa region. Valued at approximately $260 million in 2025, the market encompasses a wide range of products including interventional cardiology devices, cardiac imaging equipment, electrophysiology devices, and cardiac rhythm management systems. The UAE's position as a regional medical hub, combined with its advanced healthcare infrastructure and high healthcare spending per capita, creates a sophisticated market environment.
- •Market size reached approximately $260 million in 2025
- •Compound annual growth rate projected at 5.8% through 2030
- •UAE accounts for a significant share of the MEA cardiovascular devices market
Growth Drivers
The rising burden of cardiovascular disease in the UAE, driven by lifestyle-related factors such as diabetes, obesity, and hypertension, is a primary catalyst for market growth. Government initiatives like UAE Vision 2030 and the National Agenda prioritize healthcare excellence, spurring investment in hospital infrastructure and advanced medical technology. Additionally, medical tourism, which the UAE actively promotes, contributes to increased demand for high-quality cardiovascular care and associated devices.
- •High prevalence of lifestyle-related cardiovascular conditions in the population
- •Government healthcare spending and infrastructure development programs
- •Growing medical tourism sector increasing demand for advanced cardiac procedures
Segmentation and Regional Analysis
Within the UAE market, interventional cardiology products constitute the largest segment, followed by cardiac imaging systems and electrophysiology devices. Minimally invasive surgical procedures are gaining prominence, driving demand for advanced stents, catheters, and closure devices. The UAE's well-established hospital networks in Dubai and Abu Dhabi, featuring facilities like Cleveland Clinic Abu Dhabi and American Hospital Dubai, serve as primary distribution channels for cardiovascular device manufacturers across the MEA region.
- •Interventional cardiology dominates the product segment
- •Dubai and Abu Dhabi concentrate major healthcare facilities and device adoption
- •UAE serves as a distribution gateway for broader MEA regional markets
Trends and Outlook
What are the recent trends and outlook?
The market is witnessing increased adoption of bioresorbable stents and advanced drug-eluting technologies, reflecting a shift toward more durable and patient-friendly treatment options. Digital health integration, including AI-powered cardiac imaging analysis and remote monitoring devices, is emerging as a significant trend. The outlook through 2030 remains positive, with continued growth anticipated as healthcare facilities expand capabilities, insurance coverage widens, and the UAE reinforces its status as a regional leader in medical innovation.
- •Bioresorbable scaffolds and next-generation drug-eluting stents gaining clinical acceptance
- •Digital cardiology and AI-assisted diagnostics becoming increasingly integrated
- •Continued market expansion expected as new hospital projects come online through 2030
Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.
Connect to an analyst →Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.